Results 171 to 180 of about 12,672,734 (314)

Alignment optimization in digital implantology: evaluating the role of scan body modifications and different software. [PDF]

BMC Oral Health
Bilgin Avsar D, Ertan AA.
europepmc   +1 more source

Psychological Types of Brazilian Software Engineering Students [PDF]

, 2015
Luiz Fernando Capretz
openalex   +1 more source

PELATIHAN PENERAPAN ACCURATE ACCOUNTING SOFTWARE BAGI SISWA JURUSAN AKUNTANSI DI SMK N 1 PADANG CERMIN

, 2022
Heni Sulistiani, Fikri Hamidy, Suaidah Suaidah, Rika Mersita, Yunita Yunita, Yasinta Ismi HS   +5 more
openalex   +2 more sources

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Assessing the agreement of radiomic tools for dosiomics: A multi-software comparative study. [PDF]

Med Phys
Bettinelli A, Marturano F, Pirrone G, Gioscio E, Avanzo M, Fanizzi A, Garibaldi C, Massafra R, Menghi E, Placidi L, Rancati T, Paiusco M.   +11 more
europepmc   +1 more source

Método para Promover el Aprendizaje Colaborativo en Ingeniería de Software [PDF]

, 2019
Héctor Cornide-Reyes, Rodolfo Villarroel   +1 more
openalex   +1 more source

DhaibaWorks: A Software Platform for Human-Centered Cyber-Physical Systems

, 2023
Yui Endo, Tsubasa Maruyama, Mitsunori Tada   +2 more
openalex   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Emergency embolization of acute hemorrhage: cone-beam computed tomography with advanced planning and guidance software-a systematic review and case series. [PDF]

CVIR Endovasc
Geevarghese R, Solomon SB, Cornelis FH.
europepmc   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source